Recall all batches of NIFEDIPINE 60 mg
2026-03-10
SFDA has issued a recall of all batches of NIFEDIPINE 60 mg due to non-compliance of the active ingredient manufacturer, Valpharma international S.P.A with Good Manufacturing Practice (GMP) requirements, which may impact the safety, efficacy, and quality of the products.
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
1. Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
2. Contact the recalling firm or SFDA if you have any questions about the recall.
3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.